Table 2.
Neopterin Concentrations in Patients with SLE and RA and Current Medications
Current Medication Use | Neopterin (SLE) | Neopterin (RA) | |||||
---|---|---|---|---|---|---|---|
n | (nmol/l) | P* | n | (nmol/l) | P* | ||
Corticosteroids | |||||||
No | 63 | 7.6 [5.9–9.8] | 0.21 | 76 | 6.6 [5.4–8.6] | 0.94 | |
Yes | 85 | 8.5 [7.1–9.8] | 90 | 7.0 [4.9–8.9] | |||
Methotrexate | |||||||
No | 134 | 8.0 [6.5–9.8] | 0.87 | 48 | 7.6 [6.0–10.7] | 0.01 | |
Yes | 14 | 8.6 [7.1–11.7] | 118 | 6.4 [4.9–8.3] | |||
Antimalarials | |||||||
No | 49 | 8.7 [7.3–12.2] | 0.03 | 124 | 7.1 [5.5–9.3] | 0.12 | |
Yes | 99 | 7.7 [6.3–9.3] | 42 | 5.8 [4.8–7.5] | |||
Anti-TNF agents | |||||||
No | - | - | - | 132 | 6.9 [5.3–9.2] | 0.18 | |
Yes | - | - | - | 34 | 6.2 [5.0–8.0] |
Adjusted P value for age, sex, race, serum creatinine and the current use of other drugs.